Research

Clinical Support

Lucie Lambert, Assistant
Mihir Wanchoo, Research Assistant

If you wish to participate in any of the trials or have general questions please contact our research coordinator at 713-500-7107.

Currently Enrolling Clinical Trials

FTY-720D2306
Primary Investigator: Flavia M. Nelson, M.D.
This two year study scheduled to begin fall 2010 will be researching a new oral agent in Primary Progressive MS patients. Good candidates for this trial are patients who have failed or can’t tolerate available drugs. Patients enrolled on this trial have a 30 % chance of going into the blinded placebo arm.

Currently Enrolling Investigational Studies

BIOMARKERS
Primary Investigator: Staley A. Brod, M.D.
MS is a CNS disease in which MR brain activity is 5-10 x more frequent compared to clinical activity. We are recruiting patients with characteristic MS-like brain lesions with or without clinical signs of MS and not on disease modifying drug therapy to study the evolution of MS-like MR lesions over 2 years. We will scan subjects every 2 months for 2 years and collect blood at each visit and spinal fluid when there are changes in the MR scan. We will identify novel blood and spinal fluid proteins that synchronize with repair of brain lesions that may have therapeutic potential.

EPSTEIN-BARR VIRUS & MS
Primary Investigator: J. WIlliam Lindsey, M.D.
EBV is a common virus which has been linked to MS in several different studies. Some people think that EBV may be one of the causes of MS. Dr. Lindsey is investigating the connection between EBV and MS and is currently comparing the immune response to EBV in MS and controls. Participants in the study will donate two blood specimens about three months apart. People with definite MS who are not on interferon or glatiramer treatment are eligible to participate.

Read more